401 related articles for article (PubMed ID: 21929838)
21. Effects of meal size and composition on incretin, alpha-cell, and beta-cell responses.
Rijkelijkhuizen JM; McQuarrie K; Girman CJ; Stein PP; Mari A; Holst JJ; Nijpels G; Dekker JM
Metabolism; 2010 Apr; 59(4):502-11. PubMed ID: 19846181
[TBL] [Abstract][Full Text] [Related]
22. Appetite hormones and energy intake in obese men after consumption of fructose, glucose and whey protein beverages.
Bowen J; Noakes M; Clifton PM
Int J Obes (Lond); 2007 Nov; 31(11):1696-703. PubMed ID: 17593904
[TBL] [Abstract][Full Text] [Related]
23. Effect of two carbohydrate-modified tube-feeding formulas on metabolic responses in patients with type 2 diabetes.
Voss AC; Maki KC; Garvey WT; Hustead DS; Alish C; Fix B; Mustad VA
Nutrition; 2008 Oct; 24(10):990-7. PubMed ID: 18718737
[TBL] [Abstract][Full Text] [Related]
24. Effects of the phases of the menstrual cycle on gastric emptying, glycemia, plasma GLP-1 and insulin, and energy intake in healthy lean women.
Brennan IM; Feltrin KL; Nair NS; Hausken T; Little TJ; Gentilcore D; Wishart JM; Jones KL; Horowitz M; Feinle-Bisset C
Am J Physiol Gastrointest Liver Physiol; 2009 Sep; 297(3):G602-10. PubMed ID: 19556358
[TBL] [Abstract][Full Text] [Related]
25. alpha-Glucosidase inhibition (acarbose) fails to enhance secretion of glucagon-like peptide 1 (7-36 amide) and to delay gastric emptying in Type 2 diabetic patients.
Hücking K; Kostic Z; Pox C; Ritzel R; Holst JJ; Schmiegel W; Nauck MA
Diabet Med; 2005 Apr; 22(4):470-6. PubMed ID: 15787675
[TBL] [Abstract][Full Text] [Related]
26. Blood glucose control in healthy subject and patients receiving intravenous glucose infusion or total parenteral nutrition using glucagon-like peptide 1.
Nauck MA; Walberg J; Vethacke A; El-Ouaghlidi A; Senkal M; Holst JJ; Gallwitz B; Schmidt WE; Schmiegel W
Regul Pept; 2004 Apr; 118(1-2):89-97. PubMed ID: 14759561
[TBL] [Abstract][Full Text] [Related]
27. Arabinoxylan consumption decreases postprandial serum glucose, serum insulin and plasma total ghrelin response in subjects with impaired glucose tolerance.
Garcia AL; Otto B; Reich SC; Weickert MO; Steiniger J; Machowetz A; Rudovich NN; Möhlig M; Katz N; Speth M; Meuser F; Doerfer J; Zunft HJ; Pfeiffer AH; Koebnick C
Eur J Clin Nutr; 2007 Mar; 61(3):334-41. PubMed ID: 16988651
[TBL] [Abstract][Full Text] [Related]
28. Efficacy comparison between preprandial and postprandial insulin aspart administration with dose adjustment for unpredictable meal size.
Jovanovic L; Giammattei J; Acquistapace M; Bornstein K; Sommermann E; Pettitt DJ
Clin Ther; 2004 Sep; 26(9):1492-7. PubMed ID: 15531011
[TBL] [Abstract][Full Text] [Related]
29. Effects of breakfast meal composition on second meal metabolic responses in adults with Type 2 diabetes mellitus.
Clark CA; Gardiner J; McBurney MI; Anderson S; Weatherspoon LJ; Henry DN; Hord NG
Eur J Clin Nutr; 2006 Sep; 60(9):1122-9. PubMed ID: 16670695
[TBL] [Abstract][Full Text] [Related]
30. Glucagon-like peptide-1 (7-36) amide response to low versus high glycaemic index preloads in overweight subjects with and without type II diabetes mellitus.
Milton JE; Sananthanan CS; Patterson M; Ghatei MA; Bloom SR; Frost GS
Eur J Clin Nutr; 2007 Dec; 61(12):1364-72. PubMed ID: 17299480
[TBL] [Abstract][Full Text] [Related]
31. Postprandial Effects of Blueberry (
Stote K; Corkum A; Sweeney M; Shakerley N; Kean T; Gottschall-Pass K
Nutrients; 2019 Jan; 11(1):. PubMed ID: 30669469
[TBL] [Abstract][Full Text] [Related]
32. Predictors of incretin concentrations in subjects with normal, impaired, and diabetic glucose tolerance.
Vollmer K; Holst JJ; Baller B; Ellrichmann M; Nauck MA; Schmidt WE; Meier JJ
Diabetes; 2008 Mar; 57(3):678-87. PubMed ID: 18057091
[TBL] [Abstract][Full Text] [Related]
33. Mechanism of action of exenatide to reduce postprandial hyperglycemia in type 2 diabetes.
Cervera A; Wajcberg E; Sriwijitkamol A; Fernandez M; Zuo P; Triplitt C; Musi N; DeFronzo RA; Cersosimo E
Am J Physiol Endocrinol Metab; 2008 May; 294(5):E846-52. PubMed ID: 18334612
[TBL] [Abstract][Full Text] [Related]
34. The oligosaccharide α-cyclodextrin has modest effects to slow gastric emptying and modify the glycaemic response to sucrose in healthy older adults.
Gentilcore D; Vanis L; Teng JC; Wishart JM; Buckley JD; Rayner CK; Horowitz M; Jones KL
Br J Nutr; 2011 Aug; 106(4):583-7. PubMed ID: 21554816
[TBL] [Abstract][Full Text] [Related]
35. Postprandial lipoprotein, glucose and insulin responses after two consecutive meals containing rapeseed oil, sunflower oil or palm oil with or without glucose at the first meal.
Pedersen A; Marckmann P; Sandström B
Br J Nutr; 1999 Aug; 82(2):97-104. PubMed ID: 10743481
[TBL] [Abstract][Full Text] [Related]
36. Endogenous plasma glucagon-like peptide-1 following acute dietary fibre consumption.
Bodinham CL; Al-Mana NM; Smith L; Robertson MD
Br J Nutr; 2013 Oct; 110(8):1429-33. PubMed ID: 23507477
[TBL] [Abstract][Full Text] [Related]
37. Exenatide: effect of injection time on postprandial glucose in patients with Type 2 diabetes.
Linnebjerg H; Kothare PA; Skrivanek Z; de la Peña A; Atkins M; Ernest CS; Trautmann ME
Diabet Med; 2006 Mar; 23(3):240-5. PubMed ID: 16492205
[TBL] [Abstract][Full Text] [Related]
38. Comparison of the effects of slowly and rapidly absorbed carbohydrates on postprandial glucose metabolism in type 2 diabetes mellitus patients: a randomized trial.
Ang M; Linn T
Am J Clin Nutr; 2014 Oct; 100(4):1059-68. PubMed ID: 25030779
[TBL] [Abstract][Full Text] [Related]
39. Near-normalisation of diurnal glucose concentrations by continuous administration of glucagon-like peptide-1 (GLP-1) in subjects with NIDDM.
Rachman J; Barrow BA; Levy JC; Turner RC
Diabetologia; 1997 Feb; 40(2):205-11. PubMed ID: 9049482
[TBL] [Abstract][Full Text] [Related]
40. A randomised four-intervention crossover study investigating the effect of carbohydrates on daytime profiles of insulin, glucose, non-esterified fatty acids and triacylglycerols in middle-aged men.
Brynes AE; Mark Edwards C; Ghatei MA; Dornhorst A; Morgan LM; Bloom SR; Frost GS
Br J Nutr; 2003 Feb; 89(2):207-18. PubMed ID: 12575905
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
